Research Paper Volume 16, Issue 3 pp 2320—2339
Comprehensive analysis of ALG3 in pan-cancer and validation of ALG3 as an onco-immunological biomarker in breast cancer
Figure 3. ALG3 predictive value in response to immune checkpoint blockade (ICB). Bar plot showing the biomarker relevance of ALG3 compared to standardized cancer immune evasion biomarkers in immune checkpoint blockade (ICB) sub-cohorts. The area under the receiver operating characteristic curve (AUC) was applied to evaluate the predictive performances of the test biomarkers on the ICB response status.